SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001831283-23-000126
Filing Date
2023-11-13
Accepted
2023-11-13 16:28:38
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adr-20230930.htm   iXBRL 10-Q 1035880
2 EX-10.1 exhibit101-supplementalagr.htm EX-10.1 294834
3 EX-31.1 exhibit311-certificationof.htm EX-31.1 16791
4 EX-31.2 exhibit312-certificationof.htm EX-31.2 16803
5 EX-32.1 exhibit321-certificationof.htm EX-32.1 5286
6 EX-32.2 exhibit322-certificationof.htm EX-32.2 5299
12 adr-20230930_g1.jpg GRAPHIC 116420
  Complete submission text file 0001831283-23-000126.txt   5750347

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adr-20230930.xsd EX-101.SCH 34397
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adr-20230930_cal.xml EX-101.CAL 55340
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adr-20230930_def.xml EX-101.DEF 152239
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adr-20230930_lab.xml EX-101.LAB 438778
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adr-20230930_pre.xml EX-101.PRE 271150
52 EXTRACTED XBRL INSTANCE DOCUMENT adr-20230930_htm.xml XML 694607
Mailing Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 (609) 486-2308
LianBio (Filer) CIK: 0001831283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40947 | Film No.: 231399252
SIC: 2834 Pharmaceutical Preparations